Global Retrospective Study Comparing Consolidation ALK Tyrosine Kinase Inhibitors (TKI) to Durvalumab (durva) or Observation (obs) after Chemoradiation (CRT) in Unresectable Locally-Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC).
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要